These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Trichotillomania: Bizzare Patern of Hair Loss at 11-Year-old Girl. Zímová J; Zímová P Acta Dermatovenerol Croat; 2016 Jun; 24(2):150-3. PubMed ID: 27477178 [TBL] [Abstract][Full Text] [Related]
4. HrQoL in hair loss-affected patients with alopecia areata, androgenetic alopecia and telogen effluvium: the role of personality traits and psychosocial anxiety. Russo PM; Fino E; Mancini C; Mazzetti M; Starace M; Piraccini BM J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):608-611. PubMed ID: 30394586 [TBL] [Abstract][Full Text] [Related]
5. Telogen effluvium revisited. Rebora A G Ital Dermatol Venereol; 2014 Feb; 149(1):47-54. PubMed ID: 24566565 [TBL] [Abstract][Full Text] [Related]
6. A systematic review of acute telogen effluvium, a harrowing post-COVID-19 manifestation. Hussain N; Agarwala P; Iqbal K; Omar HMS; Jangid G; Patel V; Rathore SS; Kumari C; Velasquez-Botero F; López GAB; Vishwakarma Y; Nipu AP; Ahmed NK J Med Virol; 2022 Apr; 94(4):1391-1401. PubMed ID: 34931698 [TBL] [Abstract][Full Text] [Related]
7. Alopecia in women. Thiedke CC Am Fam Physician; 2003 Mar; 67(5):1007-14. PubMed ID: 12643360 [TBL] [Abstract][Full Text] [Related]
9. Red nail bands in conjunction with telogen effluvium as a post-COVID-19 phenomenon. Thakur V; Bisht YS; Sethi S; Jindal R Australas J Dermatol; 2022 Feb; 63(1):141-142. PubMed ID: 34958136 [No Abstract] [Full Text] [Related]
12. Female pattern alopecia and telogen effluvium: figuring out diffuse alopecia. Torres F; Tosti A Semin Cutan Med Surg; 2015 Jun; 34(2):67-71. PubMed ID: 26176282 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of patients with telogen effluvium during the pandemic: May the monocytes be responsible for post COVID-19 telogen effluvium? Koç Yıldırım S; Erbağcı E; Demirel Öğüt N J Cosmet Dermatol; 2022 May; 21(5):1809-1815. PubMed ID: 35201647 [TBL] [Abstract][Full Text] [Related]
15. Diagnosis and management of the hair loss patient. Stroud JD Cutis; 1987 Sep; 40(3):272-6. PubMed ID: 3652735 [TBL] [Abstract][Full Text] [Related]
16. NonScarring Diffuse Hair Loss in Women: a Clinico-Etiological Study from tertiary care center in North-West India. Poonia K; Thami GP; Bhalla M; Jaiswal S; Sandhu J J Cosmet Dermatol; 2019 Feb; 18(1):401-407. PubMed ID: 29774652 [TBL] [Abstract][Full Text] [Related]
17. Noninflammatory, nonpruritic alopecia of horses. Rosychuk RA Vet Clin North Am Equine Pract; 2013 Dec; 29(3):629-41. PubMed ID: 24267680 [TBL] [Abstract][Full Text] [Related]
18. Oral supplementation in female telogen effluvium: a clinical and instrumental objective evidence of efficacy and tolerability of new oral cosmetic treatment. Starace M; Carpanese MA; Alessandrini A; Bruni F; Piraccini BM Ital J Dermatol Venerol; 2023 Feb; 158(1):55-59. PubMed ID: 36645365 [TBL] [Abstract][Full Text] [Related]
19. Clinical and histological challenge in the differential diagnosis of diffuse alopecia: female androgenetic alopecia, telogen effluvium and alopecia areata--part II. Werner B; Mulinari-Brenner F An Bras Dermatol; 2012; 87(6):884-90. PubMed ID: 23197208 [TBL] [Abstract][Full Text] [Related]
20. Acute telogen effluvium triad after resolution. Contin LA; Rocha VB An Bras Dermatol; 2021; 96(5):605-608. PubMed ID: 34272075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]